PEG-Thermal IIT
ClinicalTrials.gov Identifier: NCT02490943
A pilot study of warm and cold compress to reduce injection site erythema due to peginterferon-beta-1a in multiple sclerosis.
Phase IV
The MS Center is enrolling research volunteers for a drug study in MS. A research trial using thermal methods to reduce redness and pain caused by peginterferon-beta-1a (Plegridy) injections.
Description
Study involvement up to 18 weeks, consisting of two in-clinic visits and 2 phone visits. Subjects who are enrolled will use a hot and cold compress to see if it relieves redness and pain.
Study involvement up to 18 weeks, consisting of two in-clinic visits and 2 phone visits. Subjects who are enrolled will use a hot and cold compress to see if it relieves redness and pain.
Currently enrolling
Who may be eligible to participate?
Patients with a confirmed diagnosis of Multiple Sclerosis who are receiving Plegridy for treatment.
Patients with a confirmed diagnosis of Multiple Sclerosis who are receiving Plegridy for treatment.
Investigator: Theodore Brown, M.D.
For More Information: Carey Gonzales – 425.899.5374 or CLGonzales@evergreenhealth.com
No comments:
Post a Comment